Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
(S)-4-((S)-2-((5S,8S,11S,14S,17S,20S,23S,26S,29S,32S,35S,38S,41S)-35-((1H-imidazol-5-yl)methyl)-1,44-diamino-29-(2-amino-2-oxoethyl)-11-(4-aminobutyl)-14,23-di-sec-butyl-17,26-bis(3-guanidinopropyl)-20-(4-hydroxybenzyl)-38-((R)-1-hydroxyethyl)-5,8-diisobutyl-32-methyl-1,4,7,10,13,16,19,22,25,28,31,34,37,40,44-pentadecaoxo-3,6,9,12,15,18,21,24,27,30,33,36,39-tridecaazatetratetracontan-41-ylcarbamoyl)pyrrolidin-1-yl)-3-acetamido-4-oxobutanoic acid
ID: ALA3360774
Chembl Id: CHEMBL3360774
PubChem CID: 118724477
Max Phase: Preclinical
Molecular Formula: C86H142N28O23
Molecular Weight: 1936.26
Molecule Type: Protein
Associated Items: